Back to results

Università degli studi di Catania

New phytopharmaceutical anti-breast cancer formulations: immunoliposomes containing extra virgin olive oil polyphenols

Abstract

dc:description

Olive oil has compounds that provide health benefits, including the prevention and treatment of diseases. Among olive oil compounds, the phenolic fraction has received considerable attention in recent years. Most common problems are poor absorption, low half-life, due to rapid clearance and inactivation by metabolic enzymes. The development of suitable drug delivery systems and, in particular, of liposomes and immunoliposomes, may be an appropriate strategy for the effective administration of these compounds. Trastuzumab targets the human epidermal growth factor receptor 2 (HER2), which is overexpressed in 20-30% of breast cancers. Using two breast cancer cell lines, with different HER2 expression levels, liposome and immunoliposomes decreased cancer cells viability in a dose-response manner and in correlation to their level of HER2 expression.

Degree

thesis:*
Grantor dc:publisher
Università degli studi di Catania
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • NICOLOSI, SILVIA
Contributors dc:contributor
  • CICIRATA, Federico

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
  • license:PUBBLICO - Pubblico con Copyright
  • license uri:iris.PUB02
Language dc:language
eng

Identifiers

dc:identifier.*
OAI identifier oai:identifier
oai:www.iris.unict.it:20.500.11769/586593

Chain of custody

source
Harvested from
Università degli Studi di Catania
Base URL
www.iris.unict.it/oai/request
Last updated
2026-07-24
Source record
OAI-PMH GetRecord
citation

NICOLOSI, SILVIA. New phytopharmaceutical anti-breast cancer formulations: immunoliposomes containing extra virgin olive oil polyphenols. Università degli studi di Catania, 2012. https://hdl.handle.net/20.500.11769/586593